Clareo Health | Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
Age
19–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Pathologically proven diagnosis of ovarian carcinoma, fallopian tube, or primary peritoneal not to include tumors of low malignant potential (all stage, grade, and histology)
First recurrence
Platinum sensitive as defined by disease free interval ≥ 6 months
Radiological evidence of recurrent disease on preoperative PET/diagnostic CT
Planned surgical secondary cytoreduction via laparotomy
\>18 years old
You may not be if
Secondary cytoreduction via laparoscopy or robotically assisted laparoscopy
Tumors of low malignant potential
Beyond first recurrence
With the exception of non-melanoma skin cancer, subjects with other invasive malignancies, who had (or have) any evidence of the other cancer present within the last 5 years, are excluded
Active infection requiring parenteral antibiotics
For subjects with diabetes mellitus, a blood sugar will be checked preoperatively and must be \<200 for participation in the study
